Literature DB >> 31943807

Selection for psychosocial treatment for youth at clinical high risk for psychosis based on the North American Prodrome Longitudinal Study individualized risk calculator.

Michelle A Worthington1, David J Miklowitz2, Mary O'Brien1, Jean Addington3, Carrie E Bearden4, Kristin S Cadenhead5, Barbara A Cornblatt6, Daniel H Mathalon7, Thomas H McGlashan8, Diana O Perkins9, Larry J Seidman10,11, Ming T Tsuang5, Elaine F Walker12, Scott W Woods8, Tyrone D Cannon1,8.   

Abstract

AIM: Recent findings suggest that family-focused therapy (FFT) is effective for individuals at clinical high-risk for psychosis (CHR-P). As outcomes of CHR-P individuals are quite varied, certain psychosocial interventions may be differentially effective in subgroups. The present study examined change in positive symptoms for CHR-P individuals at different levels of predicted risk for conversion to psychosis who received either FFT, a brief form of family education termed enhanced care (EC) or treatment as usual.
METHODS: Participants were drawn from the North American Prodromal Longitudinal Study (NAPLS2). A subset of NAPLS2 participants completed a randomized study involving FFT or EC. The present study includes participants from the FFT-CHR sub-study and non-randomized NAPLS2 participants. Predicted risk of conversion was calculated using the Individualized Risk Calculator for Psychosis. Robust linear regressions evaluated whether the association between predicted risk of conversion and positive symptom change differed across intervention groups.
RESULTS: A total of 94 participants from the FFT-CHR sub-study (FFT-CHR n = 50, EC n = 44) and 401 non-randomized NAPLS2 participants were included in this study. There was a treatment group by predicted risk of conversion interaction that predicted positive symptom improvement: higher risk individuals improved more with FFT-CHR than EC or the non-randomized NAPLS group, whereas lower-risk individuals did not differ in positive symptom improvement across treatment groups (FFT-CHR vs EC: P = .03, β = 20.27; FFT-CHR vs NAPLS2: P < .001, β = 28.40).
CONCLUSIONS: Intensive treatments such as FFT-CHR may be most appropriate for individuals at the highest levels of clinical risk for psychosis.
© 2020 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  early intervention; family therapy; linear models; psychotic disorders; risk

Mesh:

Year:  2020        PMID: 31943807      PMCID: PMC7358123          DOI: 10.1111/eip.12914

Source DB:  PubMed          Journal:  Early Interv Psychiatry        ISSN: 1751-7885            Impact factor:   2.732


  32 in total

1.  North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research.

Authors:  Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Barbara Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming Tsuang; Elaine F Walker; Scott W Woods; Robert Heinssen
Journal:  Schizophr Bull       Date:  2007-01-25       Impact factor: 9.306

Review 2.  Early intervention for psychosis.

Authors:  Max Marshall; John Rathbone
Journal:  Schizophr Bull       Date:  2011-09-10       Impact factor: 9.306

Review 3.  Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention.

Authors:  S M Francey; B Nelson; A Thompson; A G Parker; M Kerr; C Macneil; R Fraser; F Hughes; K Crisp; S Harrigan; S J Wood; M Berk; P D McGorry
Journal:  Schizophr Res       Date:  2010-03-26       Impact factor: 4.939

4.  Exemplification of a method for scaling life events: the Peri Life Events Scale.

Authors:  B S Dohrenwend; L Krasnoff; A R Askenasy; B P Dohrenwend
Journal:  J Health Soc Behav       Date:  1978-06

5.  Family-focused treatment for adolescents with bipolar disorder: results of a 2-year randomized trial.

Authors:  David J Miklowitz; David A Axelson; Boris Birmaher; Elizabeth L George; Dawn O Taylor; Christopher D Schneck; Carol A Beresford; L Miriam Dickinson; W Edward Craighead; David A Brent
Journal:  Arch Gen Psychiatry       Date:  2008-09

6.  Personalized Prediction of Psychosis: External Validation of the NAPLS-2 Psychosis Risk Calculator With the EDIPPP Project.

Authors:  Ricardo E Carrión; Barbara A Cornblatt; Cynthia Z Burton; Ivy F Tso; Andrea M Auther; Steven Adelsheim; Roderick Calkins; Cameron S Carter; Tara Niendam; Tamara G Sale; Stephan F Taylor; William R McFarlane
Journal:  Am J Psychiatry       Date:  2016-07-01       Impact factor: 18.112

7.  An Individualized Risk Calculator for Research in Prodromal Psychosis.

Authors:  Tyrone D Cannon; Changhong Yu; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Barbara A Cornblatt; Robert Heinssen; Clark D Jeffries; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Michael W Kattan
Journal:  Am J Psychiatry       Date:  2016-07-01       Impact factor: 18.112

8.  Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America.

Authors:  Tyrone D Cannon; Kristin Cadenhead; Barbara Cornblatt; Scott W Woods; Jean Addington; Elaine Walker; Larry J Seidman; Diana Perkins; Ming Tsuang; Thomas McGlashan; Robert Heinssen
Journal:  Arch Gen Psychiatry       Date:  2008-01

9.  Family functioning moderates the impact of psychosis-risk symptoms on social and role functioning.

Authors:  Elizabeth Thompson; Pamela Rakhshan; Steven C Pitts; Caroline Demro; Zachary B Millman; Kristin Bussell; Jordan DeVylder; Emily Kline; Gloria M Reeves; Jason Schiffman
Journal:  Schizophr Res       Date:  2018-09-08       Impact factor: 4.939

10.  Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis: A Systematic Review, Meta-analysis, and Meta-regression.

Authors:  Christoph U Correll; Britta Galling; Aditya Pawar; Anastasia Krivko; Chiara Bonetto; Mirella Ruggeri; Thomas J Craig; Merete Nordentoft; Vinod H Srihari; Sinan Guloksuz; Christy L M Hui; Eric Y H Chen; Marcelo Valencia; Francisco Juarez; Delbert G Robinson; Nina R Schooler; Mary F Brunette; Kim T Mueser; Robert A Rosenheck; Patricia Marcy; Jean Addington; Sue E Estroff; James Robinson; David Penn; Joanne B Severe; John M Kane
Journal:  JAMA Psychiatry       Date:  2018-06-01       Impact factor: 21.596

View more
  2 in total

1.  Family-focused therapy for individuals at high clinical risk for psychosis: A confirmatory efficacy trial.

Authors:  David J Miklowitz; Jean M Addington; Mary P O'Brien; Danielle M Denenny; Marc J Weintraub; Jamie L Zinberg; Daniel H Mathalon; Barbara A Cornblatt; Michelle S Friedman-Yakoobian; William S Stone; Kristin S Cadenhead; Scott W Woods; Catherine A Sugar; Tyrone D Cannon; Carrie E Bearden
Journal:  Early Interv Psychiatry       Date:  2021-08-23       Impact factor: 2.721

2.  Effects of High- versus Low-Intensity Clinician Training on Implementation of Family-Focused Therapy for Youth with Mood and Psychotic Disorders.

Authors:  David J Miklowitz; Marc J Weintraub; Filippo Posta; Danielle M Denenny; Bowen Chung
Journal:  Fam Process       Date:  2021-03-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.